Thursday, October 4, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall
Tracks: Adult ID, Epidemiology and Infection Control, Investigative ID, Pediatric ID
Presentations:
Molecular Typing of Clostridium difficile: Concordance between PCR-Ribotyping and Multilocus Sequence Typing (MLST)
Xiong Wang, DVM, PhD;
Stacy Holzbauer, DVM, MPH;
Kelly Pung, BS;
Maria Bye, MPH;
Michelle Adamczyk, BS;
Ashley Lyn Paulick, BS;
Nicholas Vlachos, MS;
Alice Guh, MD, MPH;
Alison S. Laufer-Halpin, Ph.D.;
Maria S. Karlsson, PhD;
Dave Boxrud, MSc
Burden of Clostridium difficile Infection in South Carolina: A Population-Based Study
Mariam Younas, MD;
Julie Royer, MPH;
Sharon Weissman, MD;
Linda Bell, MD;
Anton Maki Jr., M.D., MBA, FRCPC, FCAP, FACP;
Katie Stilwell Waites, MPH;
Sangita Dash, MD;
Majdi N. Al-Hasan, MBBS
Trends in C. difficile Incidence, Mortality, and NAP1/027 Strain in the Population of Monroe County, NY
Trupti Hatwar, MPH;
Rebecca Tsay, MPH, MLS;
Deborah Nelson, MSN, RN;
Christina B. Felsen, MPH;
Ghinwa Dumyati, MD, FSHEA
Implementation of a Prospective, Pharmacist-Driven Clostridium difficile PCR Pre-Authorization Process to Optimize Appropriate Testing
Erik LaChance, Pharm.D.;
Jessica Miller, Pharm.D.;
Imad Almanaseer, MD;
Jay Watson, IP Surveillance Analyst;
Robert Citronberg, MD;
Leo Kelly, MD;
Angelica Whaley, MS, MT(ASCP);
Sarah M. Wieczorkiewicz, Pharm.D., BCPS AQ-ID
Association between Socioeconomic Status Factors and Incidence of Community-Associated Clostridium difficile Infection Utilizing Factor Analysis— United States, 2014–2015
Kimberly Skrobarcek, MD;
Yi Mu, PhD;
Jennifer Ahern, PhD;
Zintars Beldavs, MS;
Geoff Brousseau, MPH;
Ghinwa Dumyati, MD, FSHEA;
Monica M. Farley, MD, FIDSA;
Stacy Holzbauer, DVM, MPH;
Marion A. Kainer, MBBS, MPH;
James I. Meek, MPH;
Rebecca Perlmutter, MPH;
Erin C. Phipps, DVM, MPH;
Lisa G. Winston, MD;
Alice Y. Guh, MD, MPH
Severity and clinical outcomes of Clostridium difficile infection based on Toxin B Assay Results
Jorge Jo Kamimoto, MD;
Sandra Susanibar, MD;
Meera Mohan, MD;
Piroon Jenjaroenpun, PHD;
Krishnan Gayathri, MD;
Juan Carlos Rico, MD;
Mary J Burgess, MD;
Ruslana Tytarenko, MS;
Nicole Emery, BS M(ASCP);
Eric Rosenbaum, MD, MPH;
Brian Walker, PHD;
Intawat Nookaew, PHD;
Atul Kothari, MD
Oral Vancomycin plus Intravenous Metronidazole for Severe Clostridium difficile Infection in Critically Ill Patients
Ana Vega, PharmD;
Teri Hopkins, PharmD, BCPS;
Emily Heil, PharmD, BCPS-AQID;
Jennifer Johnson, PhD;
Surbhi Leekha, MBBS, MPH;
Kimberly Claeys, PharmD, BCPS
Validation of the SHEA/IDSA severity criteria to predict poor outcomes among inpatients and outpatients with Clostridium difficile infection
Vanessa Stevens, PhD;
Makoto Jones, MD, MS;
Richard E. Nelson, PhD;
Karim Khader, PhD;
Matthew Samore, MD, FSHEA;
Michael Rubin, MD, PhD, FIDSA
Comparison of Clostridium difficile Infection Outcomes by Diagnostic Testing Method
Alice Guh, MD, MPH;
Kelly Hatfield, MSPH;
Lisa G. Winston, MD;
Brittany Martin, MPH;
Helen Johnston, MPH;
Geoff Brousseau, MPH;
Monica M. Farley, MD, FIDSA;
Lucy E. Wilson, MD, ScM;
Rebecca Perlmutter, MPH;
Erin C. Phipps, DVM, MPH;
Ghinwa Dumyati, MD, FSHEA;
Deborah Nelson, MSN, RN;
Trupti Hatwar, MPH;
Marion A. Kainer, MBBS, MPH;
L. Clifford McDonald, MD
Clinical Manifestations and Outcomes of Clostridium difficile Infection in Long Term Care Patients: An 8-Year Retrospective Cohort Study.
Suganya Chandramohan, MD;
Amar Krishna, MD;
Parminder Virdi, MD;
Jordon Polistico, MD;
Nikhila Thammineni, MD;
Anupamdeep Singh Mehar, MD;
Angad Singh Gill, MD;
Aleena Saleem, MD;
Ibtehaj Javed, MD;
Dania Qaryoute, MD;
Daniel Deporre, MS;
Pingping Zhang, MS STATISTICS;
Kirstin Heinrich, MPH;
Elisa Gonzalez, MSc;
Teena Chopra, MD, MPH
Long term Outcomes of Clostridium difficile Infection among Medicare Beneficiaries
Kelly M. Hatfield, MSPH;
James Baggs, PhD;
Lisa G. Winston, MD;
Erin Parker, MPH;
Brittany Martin, MPH;
James I. Meek, MPH;
Danyel Olson, MS, MPH;
Monica M. Farley, MD, FIDSA;
Andrew Revis, MPH;
Stacy Holzbauer, DVM, MPH;
Maria Bye, MPH;
Lucy Wilson, MD, ScM;
Rebecca Perlmutter, MPH;
Erin C. Phipps, DVM, MPH;
Rebecca Pierce, PhD, MS, BSN;
Valerie L.S. Ocampo, RN, MIPH;
Marion A. Kainer, MBBS, MPH;
Miranda Smith, MPH;
L. Clifford McDonald, MD;
John A. Jernigan, MD, MS;
Alice Guh, MD, MPH
Development of a simple Clostridium difficile infection clinical risk prediction tool for medical inpatients
Winnie Ma, B.Sc.(Pharm), ACPR;
Torey Lau, B.Sc.(Pharm), ACPR;
Vivian Leung, B.Sc.(Pharm), Pharm.D, ACPR;
Victoria Su, B.Sc.(Pharm), Pharm.D, ACPR;
Joseph Puyat, PhD, M.Sc, MA (Psych);
Stephen Shalansky, B.Sc.(Pharm), ACPR, Pharm.D
Predictors of C. difficile Infection and Impact of Primary Prophylaxis among Asymptomatic C. difficile Colonized Patients: A Cross Sectional Study
Dominic Poirier, MD;
Philippe Gervais, MD;
Margit Fuchs, PhD;
Jean-Francois Roussy, MD;
Bianka Paquet-Bolduc, MPA;
Sylvie Trottier, MD, PhD;
Jean Longtin, MD;
Vivian Loo, MD;
Yves Longtin, MD
Identification of Patients at Risk of Clostridium difficile Infection for Enrollment in Vaccine Clinical Trials
Vanessa Stevens, PhD;
Ellyn Russo, MS;
Yinong Young-Xu, ScD, MS, MA;
Molly Leecaster, PhD;
Yue Zhang, PhD;
Chong Zhang, MS;
Holly Yu, MSPH;
Bing Cai, PhD;
Elisa Gonzalez, MSc;
Dale N Gerding, MD, FIDSA;
Jody Lawrence, MD;
Matthew Samore, MD, FSHEA
Evaluation of Bezlotoxumab in Prevention of Recurrent C. difficile Infection: A Multicenter Single Arm Study in Outpatient Infusion Centers
Richard L. Hengel, MD;
Timothy E. Ritter, MD;
Ramesh V. Nathan, MD, FIDSA;
Lucinda J. Van Anglen, PharmD;
Claudia P. Schroeder, PharmD, PhD;
Stephen Marcella, MD, MPH;
Kevin W. Garey, PharmD, M.S.
Enhanced Sporulation and Vancomycin Resistance Associated with Clostridium difficile from Recurrent Infections.
Laura E. Tijerina-Rodriguez, MSc;
Adrián Martínez-Meléndez, MSc;
Licet Villarreal-Treviño, PhD;
Rayo Morfín-Otero, MD, PhD;
Adrian Camacho-Ortiz, MD, PhD;
Simon D. Baines, PhD;
Eduardo Rodríguez-Noriega, MD, PhD;
Elvira Garza-González, PhD
Tracking the use of soap and sanitizer for hand hygiene after caring for Clostridium difficile patients
Bryan Knepper, MPH, MS, CIC;
Sara Reese, PhD, MPH, CIC, FAPIC;
Amber Miller, MSN, RN, CIC, CSPDT;
Heather Young, MD
Longer Length of Antibiotic Therapy for Community-Acquired Pneumonia and Risk of Clostridium difficile Infection
Sarah H. Yi, PhD;
Sujan C. Reddy, MD;
Sophia V. Kazakova, MD, MPH, PhD;
Kelly M. Hatfield, MSPH;
James Baggs, PhD;
Alice Y. Guh, MD, MPH;
Preeta K. Kutty, MD;
Lauri A. Hicks, DO;
Arjun Srinivasan, MD;
L. Clifford McDonald, MD;
John A. Jernigan, MD, MS
Reducing Inappropriate Clostridium difficle Testing by Empowering Nurses
Jennifer LeRose, MPH;
Amar Krishna, MD;
Suganya Chandramohan, MD;
Michelle Bartholomew, BS;
Margaret Turner, M.Ed., CIC, RN;
Nancy Baran, MS, CIC;
Thomas Chevalier, RN, BSN, CIC;
Judy Moshos, MT (ASCP), CIC;
Samyah Mogalli, MHSA, MT(ASCP);
Lynn Semproch, MPH, CIC;
Teena Chopra, MD, MPH
Clostridium difficile Timeout: A Nurse – Driven Protocol to Optimize Testing Stewardship
Cindy Hou, DO, MA, MBA, FACOI;
Nikunj Vyas, PharmD, BCPS;
Lea Ann Kellum, MSN, RN, CCRN, CEN;
Mary Miller, RN, BSN, CIC;
Ann Marie Flory, MSN, RN, NE-BC;
Shereef Ali, PharmD, BCPS, BCCCP
Impact of a multicomponent intervention bundle on healthcare facility-onset Clostridium difficile rates
Ann Keegan, BSN, RN, CIC;
Kelli Cole, PharmD, BCPS;
Melissa Ahrens, MPH, CIC;
Mark Eckhart, MPH, LPTA, CIC;
Geehan Suleyman, MD
Use of Whole-Genome Sequencing to Guide a C. difficile Diagnostic Stewardship Program
Kunal Jakharia, MBBS;
Ghassan Ilaiwy, MD;
Siobhan Moose, RN;
Masahi Waga, -;
Joel McAlduff, MD;
Lynne Karanfil, RN, MA, CIC, FAPIC;
Patrick Mcgann, PhD;
Glenn Wortmann, MD
An EMR-based diagnostic stewardship intervention for GI mPCR aimed at reducing inappropriate C. difficile tests
Margaret E. Newman, MD;
Emily Landon, MD;
Allison Bartlett, MD, MS;
Rachel Marrs, DNP, RN, CIC;
Alexandra Seguin, BSN, RN;
Cynthia Murillo, M(ASCP), CIC;
Kathleen G. Beavis, MD;
Jessica P. Ridgway, MD, MS
New Robust Antimicrobial Stewardship Program (ASP) Results in Reduction of Clostridium difficile 30-Day Readmission
Jennifer Anthone, PharmD;
Anum Abbas, MD;
Bryan Alexander, Bryan, Pharm.D.;
Dayla Boldt, PharmD;
Sumaya Ased, PharmD;
Cassara Carroll, PharmD;
Stephen Cavalieri, PhD;
John Horne, MD;
Manasa Velagapudi, MD;
Carrie Valenta, MD;
Giri Andukuri, MD;
Richard Albert Paguia, MD;
Michael Petzar, MD;
Thamer Kassim, MD;
Elizabeth George, MD, MPH;
Eric Magliulo, BS;
Christopher Destache, PharmD;
Renuga Vivekanandan, MD
Lab Stewardship for Clostridium difficile Testing Improves Appropriate Testing While Decreases Unnecessary Testing and Saves Laboratory Resources While Dramatically Helping to Reduce C diff Standardized Infection Ratios (SIR)
Jorge P Parada, MD, MPH;
Dominique Wright, MPH;
Sylvia Suarez-Ponce, BSHCL, RN, CIC;
Elaine Trulis, MS, BSN, RN, CIC;
Purisima Linchangco, MD, MPH, CIC;
Ayat Abuihmoud, MS, CIC;
Herminia Pua, RN, BSN, CIC;
Melissa Green, BA;
Heather Hedlund, RN;
Kevin R Smith, MD;
Amanda Harrington, Ph.D.
Overdiagnosis of Clostridioides difficile with a Multiplex PCR Panel
Vaneet Arora, MD, MPH, D(ABMM);
Donna R. Burgess, RPh;
Julie A. Ribes, MD, PhD;
Sarah Cotner, PharmD, BCPS;
Katie L. Wallace, PharmD, BCPS;
Derek Forster, MD
The Perfect Storm for Improved Standardized Infection Ratio (SIR) – Recognizing More Community Onset Clostridium difficile (C diff) Infections Increases the Expected Number of C diff Cases While Also Helping to Decrease the Actual Observed Number of Hospital Onset C diff Cases
Jorge P Parada, MD, MPH;
Dominique Wright, MPH;
Ashley Boldyga, BSHSM;
Ayat Abuihmoud, MS, CIC;
Melissa Green, BA;
Heather Hedlund, RN;
Amanda Harrington, Ph.D.;
Kevin R Smith, MD
Reducing Inappropriate Hospital-Acquired Clostridium difficile Diagnoses.
Robert Duncan, MD, MPH, FIDSA, FSHEA;
Jane Eyre-Kelly, RN, CIC;
Jose Cartagena, MT, CIC;
Melissa Gawlick, MPH;
Rosemarie Delacy, RN;
Andrew Villanueva, MD
Engaging the bedside nurse in reducing Clostridium difficile infection through an innovative patient care rounding program
James Newton Jr., MD, FACP, FIDSA;
Julie Gregory, RN;
Susan Benedetti, BA, RN, CIC;
Jamie Huneycutt, BSN, RN, CIC;
Rebecca Cowie, APRN, RN, ACNS-BC, CCRN
CME Credits: Maximum of 0.00 hours of
AMA PRA Category 1 Credit™
